ArticleScientific reports2026

Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cells.

Frédéric R Santer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.